ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company ...

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing precision-engineered ...

It’s become a bit of a tradition for me to recap the Nobel Prizes in my column: In 2023, I covered Claudia Goldin’s work in ...

Shares in gene-editing specialist Intellia Therapeutics came under renewed pressure today after a patient in one of its ...

The inaugural TCCI AI-Driven Science Symposium was held in San Francisco from Monday to Tuesday, bringing together three ...

Nex-z is one of two late-stage projects on the go at Intellia, a specialist in CRISPR gene-editing co-founded by Nobel Prize ...

Silicon Valley startups are pushing the boundaries of reproductive genetics, hoping to prevent diseases as well as improve chances for a high IQ ...

Amazon (AMZN) has come out on top of rivals such as Nvidia (NVDA) when it comes to utilizing AI to fight diseases. However, it wasn’t enough to prevent shares in biotech firm Metagenomi (MGX) and new ...

Azalea's first drug candidate is a CAR-T therapy for cancer and autoimmune conditions that turns immune cells into cancer ...

A Northwestern University professor has been awarded the Nobel Prize in Economic Sciences for his historical studies on sustained economic growth through technological progress. Joel Mokyr, who has ...

Joel Mokyr, Philippe Aghion and Peter Howitt have been awarded the 2025 Nobel Prize in Economics. (Photo by Jonathan Nackstrand / AFP) / ALTERNATIVE CROP (Photo by JONATHAN NACKSTRAND/AFP via Getty ...